#11: TheMachine: GlaxoSmithKline Named a 2008 100 Best Company by Working Mother Magazine
- Focus on Healthy High Performance Wins Praise for... |
October 7, 2008
01:17:55 AM |
#10: Jason: Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder
HOUSTON, LONDON and RESEARCH TRIANGLE PARK, N.C., Nov. 2 /PRNewswire/ --... |
November 3, 2007
01:32:48 PM |
#9: NewsBot: GSK News GSK Receives Approvable Letter for Topical Antibiotic, Altabax(TM) (retapamulin ointment), 1%
PHILADELPHIA--(BUSINESS WIRE)--GlaxoSmithKline (GSK) announced today that the U.S.... |
December 22, 2006
03:06:00 PM |
#8: NewsBot: GSK News GlaxoSmithKline and EPIX Pharmaceuticals Enter Drug Discovery and Development Alliance
LONDON, PHILADELPHIA & LEXINGTON, Mass.--(BUSINESS WIRE)--GlaxoSmithKline... |
December 12, 2006
04:00:00 AM |
#7: NewsBot: GSK News FDA Issues Approvable Letter for Entereg(R) (alvimopan) for POI
EXTON, Pa. & PHILADELPHIA--(BUSINESS WIRE)--Adolor Corporation (Nasdaq: ADLR) and... |
November 6, 2006
04:00:00 AM |
#6: NewsBot: GSK News VIDEO from Medialink: New Flu Vaccine Approved by the U.S. Food and Drug Administration (FDA)
--(BUSINESS WIRE)--GlaxoSmithKline [NYSE: GSK]
announced that the U.S. Food... |
October 5, 2006
11:19:00 AM |
#5: NewsBot: GSK News GlaxoSmithKline and Adolor Report Top-Line Results From Phase 3 Studies of Alvimopan (Entereg/Entrareg(R)); Adolor to Host an Investor Conference Call and Webcast at 8:45 am ET on Tuesday, September 5, 2006
LONDON & EXTON, Pa.--(BUSINESS WIRE)--Sept. 5, 2006--GlaxoSmithKline... |
September 5, 2006
04:00:00 AM |
#4: NewsBot: GSK News GlaxoSmithKline and ChemoCentryx Enter into Drug Discovery and Development Alliance in Inflammatory Disorders
LONDON, PHILADELPHIA & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aug. 24,... |
August 24, 2006
05:30:00 AM |
#3: NewsBot: GSK News Medialink: Butt Out!
--(BUSINESS WIRE)--Quitting smoking tops the list as one of the most popular New... |
December 18, 2005
11:01:00 PM |
#2: NewsBot: GSK News Ligand Collaborator Drug Shows Encouraging Results in Thrombocytopenia; GlaxoSmithKline Releases Phase II Data; Ligand Drug for Thrombocytopenia Targeted for IND Filing 1H'06
SAN DIEGO--(BUSINESS WIRE)--Dec. 2, 2005--Ligand Pharmaceuticals Incorporated... |
December 2, 2005
04:24:00 AM |
#1: NewsBot: GSK News Women Strike a Pose for Osteoporosis
--(BUSINESS WIRE)--A free 2006 calendar is now available that encourages women to... |
October 16, 2005
10:01:00 PM |
| 
| 
| 
| 
| 
| 
